Ventricular tachycardia during dobutamine stress myocardial contrast imaging [6]

Chest

Volumn 115, Issue 1, 1999, Pages 307-308

  Poldermans, D ^a   Ten Cate, F J ^a   Elhendy, A ^a   Rocchi, G ^a   Bax, J J ^a   Vletter, W ^a   Roelandt, J R T C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; SHU 508;

AGED; CASE REPORT; CORONARY RISK; DIAGNOSTIC ACCURACY; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MALE; OXYGENATOR; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; STRESS ECHOCARDIOGRAPHY;

EID: 0032932021     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.1.307     Document Type: Letter

References (5)

1. MJ Williams J Odabashian MS Lauer Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction J Am Coll Cardiol 27 1996 132 139
2. D Poldermans M Arnese PM Fioretti Improved cardiac risk stratification in major vascular surgery with dobutamine stress echocardiography J Am Coll Cardiol 26 1995 648 653
3. E Picano W Mathias A Pingitore Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study Lancet 344 1994 1190 1192
4. MA Secknus T Marwick Evaluation of dobutamine echocardiography protocols and indications: Safety and side effects in 3,011 studies over 5 years J Am Coll Cardiol 29 1997 1234 1240
5. S Kaul Myocardial contrast echocardiography: 15 years of research and development Circulation 96 1997 3745 3760